SCHEMBL7328129

SCHEMBL7328129

Cc1ccc(S(=O)(=O)N2CCC[C@H]2C(=O)NC(Cc2ccc(OC3CCN(C)CC3)cc2)C(=O)O)cc1

nearest known ligand 0.63

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ITGA4 P13612 5/20 0.63
ITGB1 P05556 8/20 0.55
ITGA5 P08648 3/20 0.55
ITGAV P06756 2/20 0.52
ITGB7 P26010 1/20 0.52
ALDH1A1 P00352 1/20 0.52
ITGA2 P17301 1/20 0.50
FKBP1A P62942 2/20 0.48
HCRTR1 O43613 2/20 0.47
HCRTR2 O43614 2/20 0.47
CYP3A4 P08684 1/20 0.47
GAA P10253 1/20 0.46
HPGD P15428 1/20 0.46
MAPT P10636 1/20 0.46
TSHR P16473 1/20 0.45
MAPK1 P28482 1/20 0.45
KCNQ1 P51787 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7320248 0.90 ITGA4 (0.56) ITGA4ITGB1ITGA5ITGAVITGB7
SCHEMBL6714623 0.88 ITGA4 (0.66) ITGA4ITGB1ITGA5ITGAVITGB7
SCHEMBL3852211 0.87 ITGA4 (0.61) ITGA4ITGB1ITGA5ITGAVITGB7
SCHEMBL6710526 0.86 ITGA4 (0.65) ITGA4ITGB1ITGA5ITGAVITGB7
SCHEMBL7322188 0.85 ITGA4 (0.66) ITGA4ITGB1ITGA5ITGAVITGB7
SCHEMBL4556889 0.85 ITGA4 (0.77) ITGA4ITGB1ITGA5ITGAVITGB7
SCHEMBL7323451 0.85 ITGA4 (0.63) ITGA4ITGB1ITGA5ITGAVITGB7
SCHEMBL6714530 0.85 ITGA4 (0.66) ITGA4ITGB1ITGA5ITGAVITGB7
SCHEMBL7066469 0.85 ALDH1A1 (0.70) ITGA4ITGB1ITGA5ITGAVITGB7
SCHEMBL6710892 0.85 ALDH1A1 (0.70) ITGA4ITGB1ITGA5ITGAVITGB7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6492421-B1 BINDING VERY LATE ANTIGEN-4; INFLAMMATORY DISEASES SUCH AS ASTHMA, ALZHEIMER'S DISEASE, ATHEROSCLEROSIS, AIDS, DEMENTIA, DIABETES, INFLAMMATORY BOWEL DISEASE, RHEUMATOID ARTHRITIS, TISSUE TRANSPLANTATION, TUMOR METASTASIS, MYOCARDIAL ISCHEMIA ATHENA NEUROSCIENCES, INC. 2002-12-10 US claimed
EP-1001972-A1 SUBSTITUTED PHENYLALANINE TYPE COMPOUNDS WHICH INHIBIT LEUKOCYTE ADHESION MEDIATED BY VLA-4 Elan Pharmaceuticals, Inc. (US) 2000-05-24 EP claimed
WO-1999006431-A1 SUBSTITUTED PHENYLALANINE TYPE COMPOUNDS WHICH INHIBIT LEUKOCYTE ADHESION MEDIATED BY VLA-4 ELAN PHARMACEUTICALS, INC. (US) 1999-02-11 WO claimed
US-6492421-B1 BINDING VERY LATE ANTIGEN-4; INFLAMMATORY DISEASES SUCH AS ASTHMA, ALZHEIMER'S DISEASE, ATHEROSCLEROSIS, AIDS, DEMENTIA, DIABETES, INFLAMMATORY BOWEL DISEASE, RHEUMATOID ARTHRITIS, TISSUE TRANSPLANTATION, TUMOR METASTASIS, MYOCARDIAL ISCHEMIA ATHENA NEUROSCIENCES, INC. 2002-12-10 US disclosed
EP-1001972-A1 SUBSTITUTED PHENYLALANINE TYPE COMPOUNDS WHICH INHIBIT LEUKOCYTE ADHESION MEDIATED BY VLA-4 Elan Pharmaceuticals, Inc. (US) 2000-05-24 EP disclosed
WO-1999006431-A1 SUBSTITUTED PHENYLALANINE TYPE COMPOUNDS WHICH INHIBIT LEUKOCYTE ADHESION MEDIATED BY VLA-4 ELAN PHARMACEUTICALS, INC. (US) 1999-02-11 WO disclosed